title: Effect of smoking status on the efficacy of the SMART regimen in high risk asthma - Reply.
authors.affiliation: Medical Research Institute of New Zealand, Wellington, New Zealand.
authors.forename: Janine
authors.initials: J
authors.lastname: Pilcher
authors.affiliation: Medical Research Institute of New Zealand, Wellington, New Zealand.
authors.forename: Mitesh
authors.initials: M
authors.lastname: Patel
authors.affiliation: Medical Research Institute of New Zealand, Wellington, New Zealand.
authors.forename: Helen
authors.initials: H
authors.lastname: Reddel
authors.affiliation: Medical Research Institute of New Zealand, Wellington, New Zealand.
authors.forename: Dominick
authors.initials: D
authors.lastname: Shaw
authors.affiliation: Medical Research Institute of New Zealand, Wellington, New Zealand.
authors.forename: Mark
authors.initials: M
authors.lastname: Weatherall
authors.affiliation: Medical Research Institute of New Zealand, Wellington, New Zealand.
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D019819:Budesonide / Q000627:therapeutic use; D006801:Humans; D012907:Smoking
chemical_list: D018927:Anti-Asthmatic Agents; D019819:Budesonide